Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

by Jan Philipp Bewersdorf, Amer M. Zeidan
Published 2020-10-01

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

by Jan Philipp Bewersdorf, Amer M. Zeidan
Published 2021-03-01

BiTEs, DARTS, BiKEs and TriKEs—Are Antibody Based Therapies Changing the Future Treatment of AML?

by Cecily Allen, Amer M. Zeidan, Jan Philipp Bewersdorf
Published 2021-05-01

Epigenetic therapy combinations in acute myeloid leukemia: what are the options?

by Jan Philipp Bewersdorf, Rory Shallis, Maximilian Stahl, Amer M. Zeidan
Published 2019-01-01

Epigenetics in Cancer: A Hematological Perspective.

by Maximilian Stahl, Nathan Kohrman, Steven D Gore, Tae Kon Kim, Amer M Zeidan, Thomas Prebet
Published 2016-10-01

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment

by Olumide Babajide Gbolahan, Amer M. Zeidan, Maximilian Stahl, Mohammad Abu Zaid, Sherif Farag, Sophie Paczesny, Heiko Konig
Published 2017-07-01

Case Report of a Patient with Left Ventricular Assistance Device Undergoing Chemotherapy for a New Diagnosis of Lung Cancer

by Maliha Khan, Anum Wasim, Aibek E. Mirrakhimov, Blaithin A. McMahon, Daniel P. Judge, Linda C. Chu, Ashtami Banavali, Amer M. Zeidan
Published 2015-01-01

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.

by Amer M Zeidan, Jessica B Long, Rong Wang, Xin Hu, James B Yu, Scott F Huntington, Gregory A Abel, Sarah S Mougalian, Nikolai A Podoltsev, Steven D Gore, Cary P Gross, Xiaomei Ma, Amy J Davidoff
Published 2017-01-01